Shëndeti

Pfizer and AstraZeneca: The vaccine does not adequately protect against the African mutation

Pfizer and AstraZeneca: The vaccine does not adequately protect against the

The South African coronavirus variant could reduce antibody protection against the Pfizer Inc. / BioNTech vaccine by two-thirds.

The study found that the vaccine was able to neutralize the virus, but did not protect enough to avoid being affected by Covid-19, specifically the African variant.

This is bad news at the time when it was thought the vaccine would eradicate the virus. Researchers are working again on improving the vaccine and adapting to the new mutation.

However, although with lower effectiveness, the vaccine still helps to protect the body so that even in case of infection with the virus does not suffer from severe forms of the disease.

In parallel, this group of researchers is working to understand whether the Pzifer and AstraZeneca vaccines also apply to the British variant.

* The Washington Post article was adapted in Albanian by Tiranapost.al